PD1

Trending/PD1

Image of hand with "Stop Lymphoma"

Nivolumab shows significant benefit for Hodgkin’s lymphoma in Mayo Clinic co-led phase I study

ROCHESTER, Minn. — A phase I clinical trial of nivolumab found that the immune-boosting drug is a highly effective therapy for Hodgkin’s lymphoma. The multi-institution…

No information found.

Sign up